Endometriosis Medications

Endometriosis is often talked about primarily in terms of pain, but most medications used to manage it aren't simple painkillers — they work by altering the hormonal environment that allows endometrial-like tissue to grow and respond outside the uterus in the first place. That distinction matters, because it explains why treatment often looks less like taking something for a symptom and more like an ongoing strategy to reduce estrogen's effect on tissue that shouldn't be there.

Why Hormones Are the Primary Target

Endometrial-like tissue outside the uterus generally responds to the same hormonal cycle that governs a normal menstrual cycle, thickening and then breaking down in response to shifts in estrogen and progesterone. Because that tissue can trigger inflammation and scarring wherever it's located, reducing its hormonal stimulation is thought to reduce the underlying activity that drives pain and progression. This is the shared logic behind most medical treatments for endometriosis, even though they achieve it through different specific mechanisms.

Combined Hormonal Contraceptives as a Common Starting Point

Birth control pills, patches, or rings containing both estrogen and progestin are often tried first, partly because they're familiar, generally well tolerated, and can be used continuously — skipping the placebo week — to reduce or eliminate menstrual bleeding altogether. By keeping hormone levels relatively stable rather than cycling, continuous use is thought to reduce the periodic stimulation that would otherwise occur with each cycle. This approach doesn't address existing endometrial tissue directly, but it can meaningfully reduce pain for many people and is generally considered a reasonable starting point given its relatively low side-effect burden compared to more intensive options.

Progestin-Only Therapies

Progestin-only treatments — including certain pills, injections, implants, and hormone-releasing intrauterine devices — work by counteracting estrogen's effect on tissue growth and are often used for people who can't take estrogen-containing options or who haven't found sufficient relief with them. Dienogest, a progestin specifically studied for endometriosis, is thought to both reduce inflammation locally and suppress the hormonal signals driving tissue activity. Side effects vary between formulations but can include irregular bleeding, particularly in the first several months, which is generally expected rather than a sign something is wrong.

GnRH Agonists and Antagonists: A Stronger Hormonal Suppression

For more significant symptoms, doctors may consider gonadotropin-releasing hormone (GnRH) agonists, such as leuprolide, or newer GnRH antagonists, such as elagolix. These work further upstream than contraceptives, reducing the signal from the brain that tells the ovaries to produce estrogen in the first place, which brings estrogen levels down to a range similar to menopause. This is a genuinely more powerful suppression than hormonal contraceptives provide, and it's generally reserved for cases where other options haven't provided adequate relief, given the more pronounced side effects associated with significantly lowered estrogen.

Add-Back Therapy and Long-Term Considerations

Because a very low estrogen state can affect bone density and cause menopause-like symptoms such as hot flashes over time, "add-back" therapy — a small, carefully chosen amount of hormone given alongside a GnRH medication — is often used to offset these effects while largely preserving the treatment's benefit for endometriosis symptoms.